Cognition Announces Compass MED 3.0, Bringing Automated Impact Assessment and Connected Testing to Medical Device Development
Impact assessed. Tests traced. Engineering connected. Giving medical device teams one compliant source of truth. LEXINGTON, Mass., Nov. 9, 2026 /PRNewswire/ -- Cognition® Corporation, a leader in SaaS-based product development solutions for life sciences, today announced the release of...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 99 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.